MeSH term
Frequency | Condition_Probility | Female | 3 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Humans | 27 | 0.0 |
Male | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 17 | 0.0 |
Signal Transduction | 4 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Animals | 11 | 0.0 |
Binding Sites | 7 | 0.0 |
Cell Line | 7 | 0.0 |
*I-kappa B | 6 | 3.0 |
In Vitro | 2 | 0.0 |
Lipopolysaccharides/pharmacology | 2 | 0.0 |
Molecular Sequence Data | 17 | 0.0 |
Phosphorylation | 2 | 0.0 |
Mice | 5 | 0.0 |
Mice, Nude | 3 | 0.0 |
Comparative Study | 4 | 0.0 |
Cricetulus | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Transfection | 3 | 0.0 |
Base Sequence | 15 | 0.0 |
Dinucleotide Repeats | 2 | 2.0 |
Gene Frequency | 3 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Spain/epidemiology | 2 | 1.0 |
Transcription Factors/*genetics | 4 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
DNA | 4 | 0.0 |
NF-kappa B/*genetics | 7 | 15.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
Protein Precursors/*genetics | 2 | 1.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 5 | 0.0 |
Trans-Activation (Genetics) | 3 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Oligonucleotides, Antisense/pharmacology | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
NF-kappa B/*metabolism | 3 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
DNA-Binding Proteins/pharmacology | 2 | 8.0 |
Enhancer Elements (Genetics) | 3 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Antigens, CD28/*physiology | 2 | 2.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins c-rel | 4 | 7.0 |
NF-kappa B/antagonists & inhibitors/*metabolism | 2 | 3.0 |
Gene Expression Regulation | 2 | 0.0 |
Interleukin-8/*genetics | 2 | 7.0 |
Hela Cells | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Risk Factors | 2 | 0.0 |
Genotype | 3 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
